Detalles de la búsqueda
1.
Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
Cancer Immunol Immunother
; 65(5): 537-49, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26961085
2.
Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice.
PLoS One
; 11(2): e0150084, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26910562
3.
Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy.
J Immunother Cancer
; 2(1): 34, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25328681
Resultados
1 -
3
de 3
1
Próxima >
>>